The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

Britain will invest up to $767 million into a new health data research service to help boost scientific studies and cut the ...

The UK will invest up to £600 million into a new health data research service to enhance scientific studies and accelerate ...

Zantac went on sale in the UK in 1981. But in 2019, GSK withdrew it in the UK and US over fears that the ingredient ...

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.

GSK (GSK) is pushing the UK government to give pharmaceutical companies more access to its public health data in order to accelerate drug ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

GSK (GSK) plc announced a new research collaboration with the UK Dementia Research Institute and Health Data Research UK to advance ...

GSK partners with UK research groups to study if Shingrix shingles vaccine reduces dementia risk, analyzing NHS data from ...

GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my portfolio? The post Should I buy GSK shares at £15? appeared first on The Motley ...

GlaxoSmithKline is to sell off its famous bedtime malted milk drink Horlicks in the UK, and will also consider exiting a pharma business, its cephalosporins antibiotics franchise.

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The ...